Deleterious genetic influence of CX3CR1 genotypes on HIV-1 disease progression

被引:27
|
作者
Faure, S
Meyer, L
Genin, E
Pellet, P
Debré, P
Théodorou, I
Combadière, C
机构
[1] Hop La Pitie Salpetriere, INSERM U543, Paris, France
[2] INSERM, U569, Serv Epidemiol, Le Kremlin Bicetre, France
[3] Hop Bicetre, Fac Med, INSERM, U535, Le Kremlin Bicetre, France
关键词
HIV; chemokine; CX3CR1; polymorphism;
D O I
10.1097/00126334-200303010-00014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We previously reported that patients homozygous for a specific mutation (M280) in the chemokine receptor CX3CR1 progressed to AIDS more rapidly than those with other genotypes. This deleterious effect would predict that a cohort of prevalent patients would be depleted in M280 carriers, because these patients would have disappeared before recruitment. This hypothesis is confirmed ill this new Study based on the French SEROCO cohort showing that patients homozygous for the M280 allele were rare among the seroprevalent group. These results may explain the conflicting results published on the impact of CX3CR1 polymorphism in seroconverters.
引用
收藏
页码:335 / 337
页数:3
相关论文
共 50 条
  • [1] A new CX3CR1 genotype with implications for HIV disease progression
    Roman, F
    Deroo, S
    Franck, N
    Burgy, C
    Servais, J
    Schmit, JC
    AIDS, 2001, 15 (05) : 659 - 660
  • [2] Genetic Polymorphisms in CX3CR1 predict HIV-1 disease progression in children independently of CD4+ lymphocyte count and HIV-1 RNA load
    Singh, KK
    Hughes, MD
    Chen, J
    Spector, SA
    JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (11): : 1971 - 1980
  • [3] Identification of CX3CR1 -: A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1
    Combadiere, C
    Salzwedel, K
    Smith, ED
    Tiffany, HL
    Berger, EA
    Murphy, PM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) : 23799 - 23804
  • [4] Fractalkine/CX3CR1 Signaling Promotes Angiogenic Potentials in CX3CR1 Expressing Monocytes
    Kim, Jeong A.
    Kwak, Jae-Yong
    Eunjung, Yhim
    Lee, Joon
    Park, Youngrok
    Broxmeyer, Hal E.
    BLOOD, 2016, 128 (22)
  • [5] CX3CR1 in multiple sclerosis
    Rivest, Serge
    ONCOTARGET, 2015, 6 (24) : 19946 - 19947
  • [6] Fractalkine/CX3CR1 and atherosclerosis
    Liu, Hong
    Jiang, Deqian
    CLINICA CHIMICA ACTA, 2011, 412 (13-14) : 1180 - 1186
  • [7] Polymorphisms of CX3CR1 and CXCR6 receptors in relation to HAART therapy of HIV-1 patients
    Sourvinos, G.
    Passam, A.
    Krambovitis, E.
    Stavrianeas, N.
    Zagoreos, I.
    Spandidos, D. A.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S52 - S52
  • [8] CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection
    Chen, Peiqing
    Zhao, Wenjuan
    Guo, Yanjie
    Xu, Juan
    Yin, Ming
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [9] Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1
    Faure, S
    Meyer, L
    Costagliola, D
    Vaneensberghe, C
    Genin, E
    Autran, B
    Delfraissy, JF
    McDermott, DH
    Murphy, PM
    Debré, P
    Théodorou, I
    Combadière, C
    SCIENCE, 2000, 287 (5461) : 2274 - 2277
  • [10] Relationship Between CX3CR1 Genetic Polymorphism and Carotid Atherosclerosis
    Zhao, Renliang
    Wang, Yongjun
    Shen, Ruowu
    Sun, Yong
    ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2010, 38 (01): : 19 - 23